Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-585609
Filing Date
2016-05-10
Accepted
2016-05-10 16:17:05
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d177055d10q.htm 10-Q 321684
2 EX-31.1 d177055dex311.htm EX-31.1 8233
3 EX-31.2 d177055dex312.htm EX-31.2 8218
4 EX-32.1 d177055dex321.htm EX-32.1 3805
5 EX-32.2 d177055dex322.htm EX-32.2 3790
  Complete submission text file 0001193125-16-585609.txt   2419208

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20160331.xml EX-101.INS 399043
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20160331.xsd EX-101.SCH 35490
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20160331_cal.xml EX-101.CAL 46900
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20160331_def.xml EX-101.DEF 100682
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20160331_lab.xml EX-101.LAB 273919
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20160331_pre.xml EX-101.PRE 187288
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 161636008
SIC: 2834 Pharmaceutical Preparations